Oncology

With cash burn rising, Summit Therapeutics races toward a November FDA decision on its novel cancer drug ivonescimab and a major data reveal at ASCO.

New pre-clinical data shows engineered immune cells (iMacrophages) can effectively target and destroy ovarian tumors, offering hope for a new treatment era.

New research challenges long-held beliefs, revealing a high-risk subset in "safe" tumors and a surprising link between body weight and cancer recurrence.

Swedish firm Navinci launches its Omni kit, targeting the spatial interactomics market with a new tool to visualize protein networks directly in tissue.

KCIC's 2025 report shows asbestos filings hitting a new peak, driven by a dramatic rise in talc-related lawsuits and massive jury awards.

With a fourfold revenue jump, China's Yangtze River Pharmaceutical Group isn't just selling drugs; it's exporting a new model of global trust and quality.

Massive Bio and OpenAI launch a groundbreaking AI initiative to automate patient matching for clinical trials, aiming to boost health equity and speed up research.

A new federal initiative aims to eliminate paper forms in clinics, giving patients control over their health data with a simple QR code. Here's how it works.

Alliance Cancer Specialists and IDEOlogy Health unite to bring the latest cancer research directly to community care teams, enhancing patient outcomes.

With investments exceeding $1B, PCI Pharma Services is expanding its US sterile manufacturing, tackling supply chain risks and boosting domestic production.

A UK firm's breakthrough blood test for early breast cancer detection joins a prestigious EU network, aiming to personalize treatment and redefine diagnostics.

With its AI-powered blood test nearing FDA review, DELFI Diagnostics adds a top biotech CFO to its board, signaling major commercial and IPO ambitions.

RedHill Biopharma flips a capital deficit to positive equity, driven by savvy partnerships for its drugs Talicia and Bekinda and a promising R&D pipeline.

In a key human trial, Sona Nanotech's heat-based therapy saw a 60% complete response in tumors for melanoma patients who had exhausted other options.

A new consultancy service combines decades of expertise with advanced analytics to tackle the billion-dollar problem of wasted drug supply in clinical trials.

With 65% of its medical tourism revenue from Indonesia, Malaysia is doubling down on its most vital market through strategic outreach and world-class care.

NerView Surgical's NerveSense™ wins FACIT's top award, spotlighting a growing ecosystem making Ontario a global leader in oncology innovation.

A novel alpha-radiation therapy, Alpha DaRT, begins European trials, offering a new path for pancreatic cancer patients with no other treatment options.

A novel RNA vaccine targeting hidden cancer antigens gets UK approval for a clinical trial, offering new hope for patients with hard-to-treat ovarian cancer.

Winning top awards, China's Fosun Health unveils a bold strategy to become the premier gateway for Southeast Asian patients seeking advanced medical care.